Scarica l'app Stockscreener
27.90
6.91%
-2.07
Dopo l'orario di chiusura:
27.89
-0.010
-0.04%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GPCR Giù?
Forum
Previsione
Structure Therapeutics Inc Adr Borsa (GPCR) Ultime notizie
Structure Therapeutics (NASDAQ:GPCR) Shares Gap UpHere's Why - MarketBeat
Structure Therapeutics (NASDAQ:GPCR) Trading Up 6.6%What's Next? - MarketBeat
Structure Therapeutics (NASDAQ:GPCR) Earns "Buy" Rating from HC Wainwright - MarketBeat
Franklin Resources Inc. Buys 60,397 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat
Structure Therapeutics' SWOT analysis: oral obesity drug stock shows promise amid fierce competition - Investing.com
Merck moves into obesity with deal for Hansoh’s GLP-1 pill - BioPharma Dive
Structure Therapeutics (NASDAQ:GPCR) Sets New 1-Year LowWhat's Next? - MarketBeat
Structure Therapeutics (NASDAQ:GPCR) Given Market Outperform Rating at JMP Securities - MarketBeat
Structure Therapeutics Selects Lead Oral Small Molecule for Obesity Treatment - Defense World
Structure Therapeutics Inc. (NASDAQ:GPCR) Receives $85.67 Consensus PT from Brokerages - Defense World
Structure Therapeutics Advances Obesity Treatment Candidate - TipRanks
Structure Therapeutics Unveils Breakthrough Oral Obesity Drug, First-in-Class Amylin Agonist Shows Promise - StockTitan
Mcewen Mining Inc (MUX-N) QuotePress Release - The Globe and Mail
Structure Therapeutics Inc. (NASDAQ:GPCR) Short Interest Update - MarketBeat
Structure Therapeutics' SWOT analysis: oral GLP-1 stock faces fierce competition - Investing.com
Market Factors: The biggest debatesand risksfor investors looking to outperform in 2025 - The Globe and Mail
Structure Therapeutics Inc. (NASDAQ:GPCR) Receives $85.67 Average PT from Analysts - MarketBeat
Exome Asset Management LLC Makes New $5.27 Million Investment in Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat
Structure Therapeutics Inc (GPCR-Q) QuotePress Release - The Globe and Mail
Y Intercept Hong Kong Ltd Makes New $1.79 Million Investment in Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat
Stock Market Movers Today • Top Gainers & Losers - Benzinga
Pier Capital LLC Buys 33,087 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat
Wellington Management Group LLP Purchases 221,851 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat
Structure Therapeutics (NASDAQ:GPCR) Shares Gap Up – Here’s Why - Defense World
FY2024 Earnings Estimate for GPCR Issued By Leerink Partnrs - Defense World
Brokers Offer Predictions for GPCR FY2024 Earnings - MarketBeat
Leerink Partnrs Has Bearish Outlook for GPCR FY2025 Earnings - Defense World
Bank of Montreal Can Has $1.94 Million Position in Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat
Structure Therapeutics' SWOT analysis: oral GLP-1 stock shows promise amid fierce competition By Investing.com - Investing.com South Africa
84,000 Shares in Structure Therapeutics Inc. (NASDAQ:GPCR) Acquired by Readystate Asset Management LP - MarketBeat
Point72 Asset Management L.P. Purchases 820,589 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat
Structure Therapeutics' SWOT analysis: oral GLP-1 stock shows promise amid fierce competition - Investing.com India
Janus Henderson Group PLC Buys 602,609 Shares of Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat
Cinctive Capital Management LP Has $1.41 Million Stock Holdings in Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat
Structure Therapeutics Inc. (NASDAQ:GPCR) Short Interest Up 7.6% in November - MarketBeat
Baker BROS. Advisors LP Purchases New Holdings in Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat
Fmr LLC Increases Holdings in Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat
Bellevue Group AG Has $27.64 Million Stock Position in Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat
Structure Therapeutics Inc. (NASDAQ:GPCR) Shares Sold by Fred Alger Management LLC - MarketBeat
Structure Therapeutics Inc. (NASDAQ:GPCR) Shares Bought by Vestal Point Capital LP - MarketBeat
Beijing Luzhu Biotechnology Changes Hong Kong Address - MSN
Structure Therapeutics (NASDAQ:GPCR) Trading Up 9.3%Time to Buy? - MarketBeat
Down 33% in 1 Month, Should You Buy the Dip With Intellia Therapeutics Stock? - MSN
Structure Therapeutics Inc. (NASDAQ:GPCR) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Assetmark Inc. Grows Stock Position in Structure Therapeutics Inc. (NASDAQ:GPCR) - Defense World
What is Lifesci Capital's Estimate for GPCR FY2024 Earnings? - MarketBeat
FY2024 Earnings Forecast for GPCR Issued By Lifesci Capital - Defense World
GPCRStructure Therapeutics Inc. American Depositary Shares Latest Stock News & Market Updates - StockTitan
Structure Therapeutics (NASDAQ:GPCR) Trading Down 8.9%Here's What Happened - MarketBeat
Structure Therapeutics to Present at Jefferies London Healthcare Conference | GPCR Stock News - StockTitan
GSA Capital Partners LLP Purchases Shares of 30,464 Structure Therapeutics Inc. (NASDAQ:GPCR) - MarketBeat
Structure Therapeutics Reports Strong Q3 2024 Results - TipRanks
Structure Therapeutics Advances Obesity Drug Trial, Reports $915M Cash Position | GPCR Stock News - StockTitan
Structure Therapeutics Launches Phase 2b Obesity Drug Trial, Expands Testing to Higher Doses | GPCR Stock News - StockTitan
Structure Therapeutics Inc. (NASDAQ:GPCR) Shares Bought by Mirae Asset Global Investments Co. Ltd. - Defense World
Is Viking Therepautics a Buy Now? - MSN
Oral Proteins and Peptides Market to Reach $28.17 Billion by 2031 As Revealed In New Report - WhaTech
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):